Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The British approach to cholesterol: A reason for lower health costs

Richard Young, MD
Meds
November 27, 2013
Share
Tweet
Share

The American Heart Association and American College of Cardiology recently published new guidelines for screening and treating cholesterol.

In some ways these guidelines are more like the British guidelines. Instead of setting up doctors and patients to fail by calling for certain cholesterol number targets as in the old U.S. guidelines (i.e. LDL level below 100), they instead focus on putting higher risk patients on drugs called statins and then not worrying about the new cholesterol number under treatment. It’s more simply: high risk, take statin; low risk, don’t take statin.

Of course these guidelines don’t come without controversy. Some estimate the number of adults recommended to take statins will double. Others criticize the spreadsheet that comes with the guidelines as exaggerating the true risk of developing heart disease by 75% to 150%.

The other factor that has gotten less press is the definition of high risk, even if the heart disease calculator is accurate. The AHA/ACC definition of high risk is a greater than 7.5% of developing symptomatic heart disease (not death) in 10 years. The British define high risk as a 20% chance in 10 years.

This is clearly a huge difference and it speaks to the underlying cultures of the two countries. The U.S. doctors and the large foundation that supports them err on the side of assuming more is better, and any theoretical benefit — no matter how high the cost — is worth it.

The British err on the side of being sure that the benefits of drug therapy is clearly greater than the risks of adverse events, and they take costs into consideration. Some people are simply at too low a risk to justify the expense and hassle of a lifetime of drugs.

I wrote earlier about explaining why screening and treating people for high cholesterol does not save money, even in the long run.

The British people and their government are willing to tell its healthcare industry that it can’t have everything it wants, and that other societal goods improve health as well. This is one of the many reasons the British people enjoy better health at less than half the cost of the U.S.

Richard Young is a physician who blogs at American Health Scare.

Prev

Will a personalized DNA report ever be commonly ordered?

November 27, 2013 Kevin 4
…
Next

Who do you want reading your EKG?

November 27, 2013 Kevin 19
…

Tagged as: Cardiology, Medications

Post navigation

< Previous Post
Will a personalized DNA report ever be commonly ordered?
Next Post >
Who do you want reading your EKG?

ADVERTISEMENT

More by Richard Young, MD

  • When medical protocol meets family concerns

    Richard Young, MD
  • Patients in Sweden received fewer post-op opioids. Why is that?

    Richard Young, MD
  • Medicine is too complex for computers to keep up with or understand

    Richard Young, MD

More in Meds

  • The economics of medical weight loss

    Howard Smith, MD
  • Why the cannabis ethics debate is really about human suffering

    Gerald Kuo
  • Testosterone cardiovascular risk: FDA update 2025

    Martina Ambardjieva, MD, PhD
  • Are you neurodivergent or just bored?

    Martha Rosenberg
  • Pharmacy benefit manager reform vs. direct drug plans

    Leah M. Howard, JD
  • A cautionary tale about pramipexole

    Anonymous
  • Most Popular

  • Past Week

    • The loss of community pharmacy expertise

      Muhammad Abdullah Khan | Conditions
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
    • Why fee-for-service reform is needed

      Sarah Matt, MD, MBA | Physician
    • Preventing physician burnout before it begins in med school [PODCAST]

      The Podcast by KevinMD | Podcast
    • What is shared truth and why does it matter?

      Kayvan Haddadan, MD | Physician
    • Reflecting on the significance of World AIDS Day from the 1980s to now

      American College of Physicians | Conditions
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • Preventing physician burnout before it begins in med school [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why we can’t forget public health

      Ryan McCarthy, MD | Physician
    • Why pediatric leadership fails without logistics and tactics

      Ronald L. Lindsay, MD | Physician
    • Why invisible labor in medicine prevents burnout

      Brian Sutter | Conditions
    • The risk of ideology in gender medicine

      William Malone, MD | Conditions
    • The economic case for investing in tobacco cessation

      Edward Anselm, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 5 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The loss of community pharmacy expertise

      Muhammad Abdullah Khan | Conditions
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
    • Why fee-for-service reform is needed

      Sarah Matt, MD, MBA | Physician
    • Preventing physician burnout before it begins in med school [PODCAST]

      The Podcast by KevinMD | Podcast
    • What is shared truth and why does it matter?

      Kayvan Haddadan, MD | Physician
    • Reflecting on the significance of World AIDS Day from the 1980s to now

      American College of Physicians | Conditions
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • Preventing physician burnout before it begins in med school [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why we can’t forget public health

      Ryan McCarthy, MD | Physician
    • Why pediatric leadership fails without logistics and tactics

      Ronald L. Lindsay, MD | Physician
    • Why invisible labor in medicine prevents burnout

      Brian Sutter | Conditions
    • The risk of ideology in gender medicine

      William Malone, MD | Conditions
    • The economic case for investing in tobacco cessation

      Edward Anselm, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The British approach to cholesterol: A reason for lower health costs
5 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...